Michaune D. Tillman
Known title: VP, General Counsel and SecyCIK: 0002000296
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
Worthington Steel Q1 2027 earnings show 212% revenue rise but net loss. Worthington Steel reported a 212% increase in revenue for Q1 2027, largely from recent acquisitions. Despite the sales jump, earnings per share moved backward and the company posted a net loss. The earnings call highlighted both the strong top‑line growth and the profitability challenge. Shares rose about 7% after the release, while the stock remains near its 52‑week high with a high trailing P/E.
Transaction History
| GLW | ▼ Sell | Open Market | 3,260 | $675K | 5/11/2026 | View on chart |
| GLW | ▼ Sell | Tax Withholding | 2,946 | $471K | 5/4/2026 | View on chart |
| GLW | ▼ Sell | Tax Withholding | 2,238 | $102K | 5/2/2025 | View on chart |
| GLW | ▲ Buy | Grant | 18,618 | $0 | 5/2/2024 | View on chart |
| WS | ▲ Buy | Grant | 5,670 | $0 | 12/22/2023 | View on chart |
| WS | ▲ Buy | Grant | 14,208 | — | 12/1/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Corning Faces Rating Downgrade Amid AI Risk Concerns
A recent Seeking Alpha report downgraded Corning, arguing the stock carries significant risk relative to its current valuation in the AI sector. This negative sentiment contrasts with other recent coverage highlighting Corning's new long-term deals in life sciences and its role in the growing cell culture market. The mixed narrative reflects a market weighing the company's strong fundamental partnerships against concerns about its high price-to-earnings ratio.
Corning Faces Rating Downgrade Amid AI Risk Concerns. A recent Seeking Alpha report downgraded Corning, arguing the stock carries significant risk relative to its current valuation in the AI sector. This negative sentiment contrasts with other recent coverage highlighting Corning's new long-term deals in life sciences and its role in the growing cell culture market. The mixed narrative reflects a market weighing the company's strong fundamental partnerships against concerns about its high price-to-earnings ratio.